Product Data Sheet

VBY-825

Catalog No. A21069

main product photo
VBY-825 is a novel, reversible cathepsin inhibitor with high potency against cathepsins B, L, S and V.
Adooq's VBY-825 has been cited by 1 publications
  • Laura Odongo, .et al. , Microbiol Spectr, 2023, Sep 20;11(5):e0190823 PMID: 37728342
  • Chemical Information
    Catalog NumA21069
    M. Wt535.55
    FormulaC23H29F4N3O5S
    Purity>98%
    Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
    CAS No.1310340-58-9
    SynonymsVBY 825, VBY825
    SMILESCC[C@H](NC([C@@H](N[C@@H](C1=CC=C(F)C=C1)C(F)(F)F)CS(=O)(CC2CC2)=O)=O)C(C(NC3CC3)=O)=O
    Biological Activity
    DescriptionVBY-825 is a novel, reversible cathepsin inhibitor with high potency against cathepsins B, L, S and V.
    RETURN POLICY
    Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
    SHIPPING AND STORAGE
    Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.